Watchlist for January 14, 2008

Good earnings news and a rash of analyst upgrades have the futures flying this morning. It's looking like a good day to be a bull but they still need to push the market above those broken August trendlines.

In other news, my new account is finally funded. Look for a huge volume surge as I jump back into the fray today. ;-)

On Today's Calendar:

nothing

More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic

Potential swing trades:

See one of the recent 'Chart Reading' posts for some potential swing candidates.

Potential day trades:

(From Briefing.com)

Gapping Down

In reaction to weak earnings/guidance: HAR -18.8%, SHLD -9.8% (also hearing downgraded to Sell at tier 1 firm and downgraded to Underperform at Credit Suisse), SNS -9.3%, TTI -6.3%, CPWR -5.6%, MTB -3.7%... Other news: OPWV -7.3% (appoints new Chairman of the Board and interim CFO), SOV -7.3% (expects fourth quarter charges), MBI -3.6% (sells $1 bln 25-yr surplus notes yielding 14%), GRMN -3.4% (Harmon lowered guidance cites industry-wide PND pricing pressure, Wedbush cut tgt to $97 from $134), FBR -3.0% (subsidiary First NLC to liquidate; does not expect to recover its remaining $12 mln investment), SNP -2.6% (still checking)... Analyst downgrades: ACF -6.6% (downgraded to Underperform at Friedman billings), TSL -4.1% (downgraded to Sell at Merrill), COH -3.2% (hearing downgraded to Neutral at tier 1 firm), ESRX -1.9% (downgraded to Neutral at JPMorgan), ARO -1.6% (downgraded to Sell at Merrill).

Gapping Up

In reaction to strong earnings/guidance: SSTR +12.7%, IBM +8.5%, SANM +7.7%, FCSX +6.4%, NILE +3.1%, LPL +2.1%... M&A news: ASVI +42.4% (to be acquired by TEX for $18/share), GCGC +33.3% (to be acquired by AngloGold Ashanti for $14.38/share)... Select gold stocks showing strength with gold trading +1.5% and setting a new record high: DROOY +13.8%, AUY +4.9% (Cramer makes positive comments and has CEO as guest on MadMoney), AU +2.8%, HMY +2.8%, GFI +2.3%... Other news: ANX +53.7% (says ANX-530 demonstrates statistically significant reduction in injection site reactions), CGEN +7.5% (announces discovery and license option agreement with Merck), WCG +6.4% (C.M.S approves service area expansion application and contract renewal in 8-K), SEED +5.4% (continues Friday's momentum into the close), NOK +5.0% (still checking), NWA +3.7% (CEO says company could benefit from merger - AP; also upgraded to Outperform at Credit Suisse), TEX +3.2% (Barron's makes positive comments and mentions as take-over tgt; Cramer also make positive comments on MadMoney), IFX +3.1% (still checking), KG +3.0% (reports FDA approval of revised labeling regarding purity of THROMBIN-JMI; hearing upgraded to Buy at tier 1 firm), ALU +2.9% (still checking), UBS +2.0-% (may be split up, face more writedowns, SonntagsZeitung says - Bloomberg),AAPL +1.9% (estimates on strong PC demand - BofA), E +1.9% (reaches Kashagan accord with Eni-led consortium - FT),BHP +1.6% (may sweeten bid for Rio Tinto - The Australian), RTP +1.2% (BHP may sweeten bid for Rio Tinto - The Australian)... Analyst upgrades: ADCT +4.7% (upgraded to Outperform at Credit Suisse), VCLK +4.2% (upgraded to Outperform at RBC), YGE +4.1% (initiated with Buy at Merrill; also tgt raised to $65 at Piper Jaffray ), RFMD +3.2% (upgraded to Hold at Deutsche Bank), BBBY +2.9% (upgraded to Outperform at Credit Suisse), UA +2.2% (upgraded to Buy at Citigroup), SJR +1.9% (upgraded to Buy at UBS and upgraded to Buy at Merrill), LOW +1.7% (upgraded to Outperform at Credit Suisse), CEG +1.7% (added to Top Pick list at Citigroup), HD +1.6% (upgraded to Outperform at Credit Suisse), NARA +1.4% (initiated with Buy at B. Riley), KDN +1.2% (upgraded to Buy at Deutsche Bank), CVS +1.2% (added to Recommended List at Citigroup), ELNK +1.2% (initiated with Buy at B. Riley), BRL +1.0% (added to Top Pick list at Friedman Billings).